Isabella practices general corporate and securities law. She represents private and public companies in a range of industries, as well as investors and underwriters. Her practice includes entity formation and organization, corporate governance matters, venture capital and other private financings, public offerings, Securities and Exchange Commission reporting and compliance, and mergers & acquisitions.
Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.
Cooley advised Cresta, an end-to-end generative artificial intelligence (AI) platform for contact centers, on the closing of its $125 million Series D.
